Approval · Notice of Compliance 626 · 2003
INVANZ: Notice of Compliance 626
Issued May 12, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 626
- Date
- May 12, 2003
- Company
- Merck Frosst Canada & Cie, Merck Frosst Canada & Co.Kirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Antibiotic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| INVANZ | 02247437 | Marketed |
Medicinal ingredients
- ERTAPENEM SODIUM 1 G per VIAL